FB Pixel no scriptT. K. Lin | KrASIA
MENU
KrASIA

T. K. Lin

[email protected]

T. K. Lin

Insights

Has China become too risky a home for AI startups? Manus thinks so

With chip access in flux and scrutiny mounting, Manus has left China for Singapore, betting that neutrality offers a safer path forward.

3 mins read
  • The Hong Kong-listed firm is advancing its pipeline using an mRNA system it says can compete with the industry’s best.

    Features

    Everest Medicines targets global expansion with proprietary, AI-driven mRNA platform

    7 mins read